- Home
- PBYI vs HDL Comparison
PBYI vs HDL Comparison
Compare PBYI & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | HDL |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 560.1M | 601.9M |
| IPO Year | 2011 | 2023 |
Fundamental Metrics
Financial Performance| Metric | PBYI | HDL |
|---|---|---|
| Price | $10.44 | $9.90 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.93 |
| AVG Volume (30 Days) | ★ 339.7K | 1.8K |
| Earning Date | 11-05-2026 | 11-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $27,685,000.00 | N/A |
| Revenue This Year | N/A | $9.19 |
| Revenue Next Year | $1.33 | $14.22 |
| P/E Ratio | $132.06 | ★ $55.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.58 | $9.74 |
| 52 Week High | $11.50 | $18.33 |
Technical Indicators
Market Signals| Indicator | PBYI | HDL |
|---|---|---|
| Relative Strength Index (RSI) | 52.90 | 34.53 |
| Support Level | $9.04 | N/A |
| Resistance Level | $11.50 | $14.04 |
| Average True Range (ATR) | 0.46 | 0.22 |
| MACD | -0.04 | -0.06 |
| Stochastic Oscillator | 39.77 | 7.26 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company, and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.